Erik B. Nelson

A strategic thinker in the application of clinical psychiatry, Dr. Erik B. Nelson serves as a Professor of Clinical Psychiatry & Behavioral Neuroscience at the University of Cincinnati College of Medicine. With a robust educational foundation, he earned his MD from the University of Cincinnati College of Medicine and completed his residency in General Psychiatry at the University of Cincinnati/University Hospital. His commitment to advancing the field is further demonstrated by his certification from the American Board of Psychiatry and Neurology in Psychiatry. Dr. Nelson's expertise lies in the nuanced areas of Psychiatry, Major Depressive Disorder, and Treatment Resistant Depression. His research interests are deeply rooted in understanding and addressing the complexities of depression, a field in which he has made significant contributions. He is particularly focused on developing innovative treatment strategies for individuals who do not respond to conventional therapies. Throughout his career, Dr. Nelson has been an active contributor to the academic community, authoring numerous peer-reviewed articles. His work has been featured in prestigious journals such as Human Brain Mapping, Neurobiology of Stress, and Alcoholism, Clinical and Experimental Research. These publications underscore his dedication to exploring the intricate relationships between brain function and psychiatric disorders. In addition to his research, Dr. Nelson is committed to education and mentorship, guiding the next generation of psychiatrists and researchers. His approach to teaching emphasizes the integration of clinical practice with cutting-edge research, ensuring that students are well-equipped to tackle the challenges of modern psychiatry. Dr. Nelson's contributions extend beyond academia; he is actively involved in various professional organizations where he collaborates with fellow experts to advance the understanding and treatment of psychiatric conditions. His work continues to influence the field, offering hope and improved outcomes for patients struggling with depression.